Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-31
2006-10-31
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S365000, C514S372000, C514S374000, C546S268100, C548S146000, C548S206000, C548S215000, C549S357000
Reexamination Certificate
active
07129254
ABSTRACT:
Conjugates of epothilones and epothilone derivatives (as effectors) with suitable biomolecules (as recognition units) are described. Their production is carried out by the effectors being reacted with suitable linkers, and the compounds that are produced are conjugated to the recognition units. The pharmaceutical use of the conjugates for treating proliferative or angiogenesis-associated processes is described.
REFERENCES:
patent: 4552893 (1985-11-01), Gleason et al.
patent: 5942555 (1999-08-01), Swan et al.
patent: 6075120 (2000-06-01), Cheronis et al.
patent: 6410301 (2002-06-01), Julien et al.
patent: 6441213 (2002-08-01), Musa et al.
patent: 6864330 (2005-03-01), Schneider et At.
patent: 2002/0045609 (2002-04-01), Ashley et al.
patent: 2002/0058286 (2002-05-01), Zhicai et al.
patent: 2002/0058817 (2002-05-01), Danishefsky et al.
patent: 2004/0242854 (2004-12-01), Osborn et al.
patent: 0121350 (1984-10-01), None
patent: 1156053 (2001-11-01), None
patent: WO 94/11021 (1994-05-01), None
patent: WO 01/64650 (2001-09-01), None
patent: WO 01/83800 (2001-11-01), None
patent: WO 01/92255 (2001-12-01), None
patent: WO 03/005026 (2003-01-01), None
Bersuker I B et al.,: “Improved Electron-Conformational Method of Pharmacophore Identification and Bioactivity Prediction. Application to Angiotensin Converting Enzyme Inhibitors” Journal of Chemical Informaiton and Computer Sciences. 2000 Nov.-Dec., vol. 40, No. 6, Nov. 2000 pp. 1363-1376.
Wang Lai-Xi et al: “Carbohydrate-Centered Maleimide Cluster as a New Type of Templates for Multivalent Peptide Assembling: Synthesis of Multivalent HIV-1 gp41 Peptides.” Bioorganic and Medicinal Chemistry, vol. 11, No. 1,2 Jan. 2003, pp. 159-166.
Reghunadhan Nair C P et. al.: “Free Readical Copolymerisation of N-(4-Hydroxyphenyl) Maleimide with Vinyl Monomers: Solvent and Penultimate-Unit Effects” European Polymer Journal, Pergamon Press Ltd. Oxford, GB., vol. 35, No. 10, Jul. 28, 1999, pp. 1829-1840.
Kalgutkar A S et al.: “Inactivation of Prostaglandin Endoperoxide Synthase (PGHS) by N-(Substituted) Maleimides” Advances in Experimental Medicine and Biology. 1997, vol. 407, 1997, pp. 79-85.
Berger Markus
Bosslet Klaus
Klar Ulrich
Menrad Andreas
Siemeister Gerhard
Millen White Zelano & Branigan P.C.
Schering Aktiengesellschaft
Solola Taofiq
LandOfFree
Effector conjugates, process for their production and their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Effector conjugates, process for their production and their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Effector conjugates, process for their production and their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3630311